Feb 16 (Reuters) - Iovance Biotherapeutics said on Friday the U.S. health regulator had granted accelerated approval for its therapy, the first of its kind, as first treatment option for adult patients with advanced melanoma, the deadliest form of skin cancer.
(Reporting by Pratik Jain in Bengaluru; Editing by Shinjini Ganguli)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Retirement savings play a crucial role in securing financial stability in your golden years. For those aiming high, being in the top 3% of retirees in terms of savings enhances comfort and offers greater financial freedom. Using data from the Federal Reserve's Survey of Consumer Finances, a 2024 survey by the Employee Benefit Research Institute, reveals that individuals with over $1 million in retirement accounts rank in the top 3% of retirees. Only 3.2% of retirees have surpassed the $1 million
The $50 million purchase could turn into Nvidia's biggest investment.
These proven wealth builders could be exactly what you're searching for right now.
$10,000 to each of these companies could deliver major returns over the next decade.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
Lots of companies are trying to capitalize on the AI revolution, but one company sticks out from the pack.
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
The number probably isn't anywhere near what you think it is.